Opventi

Medicinal product

(Invented) name

Opventi

Active substance (s)

Sitagliptinas/Dapagliflozinas

Strength

100 mg/10 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A10BD29, sitagliptin and dapagliflozin

Marketing authorisation holder

Egis Pharmaceuticals PLC, Vengrija

Date of authorisation

2026-03-04

Date of renewal

Documents

5976_pakuotes lapelis_2026-03-04.docx

5976_Opventi.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10b

Procedure number

SE/H/2626/006/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Sitagliptinas	100 mg
Dapagliflozinas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
120220	106325	1106325	lizdinė plokštelė	N30		Receptinis	LT/1/26/5976/001	Netiekiama	-	-	No	-	-
120221	106326	1106326	lizdinė plokštelė	N60		Receptinis	LT/1/26/5976/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-03-04	Registruotas